Skip to main content

Table 2 Serum visfatin levels in different number of coronary lesions

From: Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction

Variables

Case (n)

Visfatin (ng/mL)

control group

55

6.74 (5.76,7.53)

Single vessel coronary lesions

70

7.68 (6.37,9.65)*

Double vessel coronary lesions

57

7.67 (6.66,8.92)*

Multiple vessel coronary lesions

56

8.14 (6.63,11.60)*

  1. * Compared with control group, P <0.05